Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-002580
Filing Date
2012-03-14
Accepted
2012-03-14 08:59:20
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2208116z10-k.htm 10-K 1141002
2 EX-23.1.1 a2208116zex-23_11.htm EX-23.1.1 2695
3 EX-31.1.1 a2208116zex-31_11.htm EX-31.1.1 7793
4 EX-31.2.1 a2208116zex-31_21.htm EX-31.2.1 7805
5 EX-32.2.1 a2208116zex-32_11.htm EX-32.1.1 5069
12 G1003241.JPG g1003241.jpg GRAPHIC 78754
  Complete submission text file 0001047469-12-002580.txt   4255855

Data Files

Seq Description Document Type Size
6 EX-101.INS osir-20111231.xml EX-101.INS 536287
7 EX-101.SCH osir-20111231.xsd EX-101.SCH 20975
8 EX-101.CAL osir-20111231_cal.xml EX-101.CAL 57071
9 EX-101.LAB osir-20111231_lab.xml EX-101.LAB 319339
10 EX-101.PRE osir-20111231_pre.xml EX-101.PRE 147230
11 EX-101.DEF osir-20111231_def.xml EX-101.DEF 99991
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 12688974
SIC: 2836 Biological Products, (No Diagnostic Substances)